
Chemicals & Petrochemicals
Valuation | |
|---|---|
| Market Cap | 13.74 kCr |
| Price/Earnings (Trailing) | 33.89 |
| Price/Sales (Trailing) | 5.68 |
| EV/EBITDA | 22.56 |
| Price/Free Cashflow | 180.94 |
| MarketCap/EBT | 25.19 |
| Enterprise Value | 13.54 kCr |
Fundamentals | |
|---|---|
Growth & Returns | |
|---|---|
| Price Change 1W | 10.2% |
| Price Change 1M | 4.9% |
| Price Change 6M | -7.4% |
| Price Change 1Y | 3% |
| 3Y Cumulative Return | -1.7% |
| 5Y Cumulative Return | 13.2% |
| 7Y Cumulative Return | 22.3% |
Cash Flow & Liquidity |
|---|
| Revenue (TTM) |
| 2.42 kCr |
| Rev. Growth (Yr) | 0.10% |
| Earnings (TTM) | 405.45 Cr |
| Earnings Growth (Yr) | -7.6% |
Profitability | |
|---|---|
| Operating Margin | 22% |
| EBT Margin | 23% |
| Return on Equity | 16.37% |
| Return on Assets | 15.24% |
| Free Cashflow Yield | 0.55% |
| Cash Flow from Investing (TTM) | -668.61 Cr |
| Cash Flow from Operations (TTM) | 204 Cr |
| Cash Flow from Financing (TTM) | -34.34 Cr |
| Cash & Equivalents | 214.39 Cr |
| Free Cash Flow (TTM) | 76.4 Cr |
| Free Cash Flow/Share (TTM) | 24.92 |
Balance Sheet | |
|---|---|
| Total Assets | 2.66 kCr |
| Total Liabilities | 183.17 Cr |
| Shareholder Equity | 2.48 kCr |
| Current Assets | 2.02 kCr |
| Current Liabilities | 170.18 Cr |
| Net PPE | 370.89 Cr |
| Inventory | 399.4 Cr |
| Goodwill | 0.00 |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.00 |
| Debt/Equity | 0.00 |
| Interest Coverage | 258.83 |
| Interest/Cashflow Ops | 98.31 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 11 |
| Dividend Yield | 0.25% |
| Shares Dilution (1Y) | 0.00% |
| Shares Dilution (3Y) | 0.00% |
Size: Market Cap wise it is among the top 20% companies of india.
Balance Sheet: Strong Balance Sheet.
Momentum: Stock price has a strong positive momentum. Stock is up 4.9% in last 30 days.
Profitability: Very strong Profitability. One year profit margin are 17%.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Past Returns: Underperforming stock! In past three years, the stock has provided -1.7% return compared to 12.8% by NIFTY 50.
Smart Money: Smart money looks to be reducing their stake in the stock.
Size: Market Cap wise it is among the top 20% companies of india.
Balance Sheet: Strong Balance Sheet.
Momentum: Stock price has a strong positive momentum. Stock is up 4.9% in last 30 days.
Profitability: Very strong Profitability. One year profit margin are 17%.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Past Returns: Underperforming stock! In past three years, the stock has provided -1.7% return compared to 12.8% by NIFTY 50.
Smart Money: Smart money looks to be reducing their stake in the stock.
Investor Care | |
|---|---|
| Dividend Yield | 0.25% |
| Dividend/Share (TTM) | 11 |
| Shares Dilution (1Y) | 0.00% |
| Earnings/Share (TTM) | 132.24 |
Financial Health | |
|---|---|
| Current Ratio | 11.87 |
| Debt/Equity | 0.00 |
Technical Indicators | |
|---|---|
| RSI (14d) | 63.56 |
| RSI (5d) | 83.87 |
| RSI (21d) | 62.45 |
| MACD Signal | Buy |
| Stochastic Oscillator Signal | Hold |
| SharesGuru Signal | Buy |
| RSI Signal | Hold |
| RSI5 Signal | Sell |
| RSI21 Signal | Hold |
| SMA 5 Signal | Buy |
| SMA 10 Signal |
Summary of Fine Organic Industries's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
Management's outlook for Fine Organic Industries Limited reflects confidence amidst a challenging macroeconomic environment. The company navigated increased raw material costs and logistics challenges effectively, reporting a revenue increase of 6.9% to INR 2,269 crores for FY '25, up from INR 2,123 crores the previous year. However, EBITDA declined by 4% to INR 512.9 crores, with EBITDA margins at 22.6%. The profit after tax (PAT) was slightly lower at INR 410.5 crores compared to INR 411.9 crores in FY '24.
Key forward-looking points include:
Overall, Fine Organic's strategy positions it for growth by leveraging both domestic and international markets while adapting to evolving consumer needs and operational efficiencies.
Understand Fine Organic Industries ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| Tushar Ramesh Shah | 16.26% |
| Jayen Ramesh Shah | 15.7% |
| Bimal Mukesh Shah | 10.44% |
| Anjali Kunal Patil | 7.49% |
| Archana Yatin Sankholkar | 7.49% |
| Mukesh Maganlal Shah | 6.26% |
| AXIS MUTUAL FUND TRUSTEE LIMITED A/C AXIS MUTUAL F | 4.06% |
Detailed comparison of Fine Organic Industries against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| ATUL | Atul | 18.41 kCr | 6.22 kCr | +1.20% | +0.80% | 30.98 | 2.96 | - | - |
| VINATIORGA | Vinati Organics | 15.87 kCr | 2.31 kCr |
Comprehensive comparison against sector averages
FINEORG metrics compared to Chemicals
| Category | FINEORG | Chemicals |
|---|---|---|
| PE | 34.16 | 44.71 |
| PS | 5.72 | 4.17 |
| Growth | 6.8 % | 6.2 % |
Fine Organic Industries Limited engages in manufacture, processing, supply, distribution, dealing, import, and export of oleochemical-based additives in India and internationally. The company offers food additives, such as emulsifiers, antifungal agents, bread improvers, beverage clouding agents, and other specialized blends; polymer additives for various types of polymers, rubbers and elastomers, etc.; cosmetic and pharmaceutical additives; feed nutrition additives; coating additives; and additives for other specialty application in various industries. It products are used in foods, plastics, cosmetics, coatings, and other specialty applications. Fine Organic Industries Limited was founded in 1970 and is headquartered in Mumbai, India.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
| Buy |
| SMA 20 Signal | Buy |
| SMA 50 Signal | Buy |
| SMA 100 Signal | Buy |
FINEORG vs Chemicals (2021 - 2026)
Question: Can you now give us the sense on what is the capex in the JNPA, the new facility that we are planning? Answer: Our total capex for the new facility at JNPA is anticipated to be around INR 750 crores, though this will be implemented in stages as we progress through the approvals needed for construction.
Question: Will we be able to consume all of our cash in the expansion plan in the U.S. as well, or will there still be cash left? Answer: Yes, we are looking at both the SEZ and U.S. expansions, which will consume a significant portion of our cash reserves, currently around INR 1,000 crores. However, we will retain some cash for potential M&A opportunities we are exploring.
Question: How do you see growth over the next 3 to 5 years post-expansion? Answer: While I can't provide specific numbers, I'm confident that both U.S. and SEZ expansions will significantly boost our capacities. The first phases will easily fill existing export demands. This gives us room for domestic growth as well.
Question: What is your readiness to tackle U.S. regulations and labor laws? Answer: We are cautious about U.S. operations as this is our first plant there. We need to understand local regulations and hire the right management. We're prepared to learn from the challenges we might face during this initial phase of operations.
Question: Can you elaborate on the investment in other financial assets? Answer: We have invested approximately INR 200 crores in long-term fixed deposits, which is reflected as an increase in our non-current assets. This strategy helps ensure liquidity while also earning returns.
Question: What's the status of the Thailand expansion related to super specialty products? Answer: We've received the necessary FDA approvals and started trial production of these specialty products. Our production team in Thailand is confident, and we are running trials smoothly, with commercial lots also being produced.
Question: Will the U.S. expansion focus solely on manufacturing the same products as in India? Answer: Initially, the U.S. facility will produce products we currently export from India. As we progress, we intend to expand our range to include both existing and new products.
Question: Are you open to raising funds or debt for the upcoming expansions? Answer: Yes, we are open to raising funds through debt financing. Our expansion strategies will be financed through a combination of internal accruals and debt.
Question: What do you expect your capacity to be in the U.S. compared to India? Answer: While I can't provide exact figures just yet, we expect the capacity in the U.S. to be higher than in India. We are still working out the specifics as negotiations with suppliers are underway.
Question: How would you respond to increasing domestic demand while managing underutilized capacity? Answer: Our Patalganga plant is focused on food additives and is ramping up quickly. We foresee full utilization by early FY '26 but cannot manufacture anything outside of food additives there. Hence, JNPA will help meet rising domestic demand by freeing capacity from existing plants.
| NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA SMA | 2.56% |
| SBI SMALL CAP FUND | 2.17% |
| Neeta Jayen Shah | 2% |
| Bina Tushar Shah | 1.87% |
| Jayshree Mukesh Shah | 1.85% |
| Akruti Bimal Shah | 1.46% |
| R M Shah - HUF (Karta - Jayen Ramesh Shah) | 1.01% |
| Jayen R Shah HUF (Karta - Jayen Ramesh Shah) | 1% |
| Esha Tushar Shah | 0.68% |
| Rhea Tushar Shah | 0.68% |
| Manali Vishal Doshi | 0.4% |
| Shaili Nirav Doshi | 0.4% |
| Tushar R Shah HUF (Karta - Tushar Ramesh Shah) | 0% |
Distribution across major stakeholders
Distribution across major institutional holders
| -5.20% |
| -13.60% |
| 35.83 |
| 6.87 |
| - |
| - |
| GALAXYSURF | Galaxy Surfactants | 6.48 kCr | 4.82 kCr | -8.10% | -25.00% | 22.64 | 1.35 | - | - |
| BALAMINES | Balaji Amines | 3.58 kCr | 1.41 kCr | +3.10% | -36.40% | 24.98 | 2.54 | - | - |
| 475 |
| 477 |
| 503 |
| 428 |
| 458 |
| 422 |
| Profit Before exceptional items and Tax | -5.3% | 143 | 151 | 130 | 115 | 160 | 152 |
| Exceptional items before tax | -116.7% | 0 | 6.98 | 0 | 0 | 0 | 0 |
| Total profit before tax | -9.6% | 143 | 158 | 130 | 115 | 160 | 152 |
| Current tax | -13.5% | 33 | 38 | 33 | 32 | 42 | 38 |
| Deferred tax | -155.6% | 0.31 | 2.24 | -0.21 | -0.41 | -0.49 | -0.12 |
| Total tax | -17.9% | 33 | 40 | 33 | 32 | 42 | 38 |
| Total profit (loss) for period | -6.9% | 109 | 117 | 97 | 83 | 117 | 113 |
| Other comp. income net of taxes | -5.4% | -6.25 | -5.88 | -1.7 | -0.02 | -0.24 | -0.4 |
| Total Comprehensive Income | -8.2% | 102 | 111 | 95 | 83 | 117 | 113 |
| Earnings Per Share, Basic | -7.5% | 35.4 | 38.19 | 31.68 | 26.97 | 38.3 | 36.938 |
| Earnings Per Share, Diluted | -7.5% | 35.4 | 38.19 | 31.68 | 26.97 | 38.3 | 36.938 |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| Cost of Materials | 27.8% | 1,363 | 1,067 | 1,923 | 1,220 | 715 | 636 |
| Cost of Materials | - | - | - | - | - | - | - |
| Purchases of stock-in-trade | - | 3.3 | 0 | 0 | 0 | 0.04 | 0 |
| Employee Expense | 13.3% | 129 | 114 | 101 | 85 | 76 | 69 |
| Employee Expense | - | - | - | - | - | - | - |
| Finance costs | -47.7% | 1.69 | 2.32 | 4.47 | 5.06 | 6.09 | 4.78 |
| Finance costs | - | - | - | - | - | - | - |
| Depreciation and Amortization | -9.1% | 51 | 56 | 48 | 40 | 47 | 35 |
| Depreciation and Amortization | - | - | - | - | - | - | - |
| Other expenses | 11.4% | 264 | 237 | 282 | 230 | 127 | 114 |
| Other expenses | - | - | - | - | - | - | - |
| Total Expenses | 16.2% | 1,777 | 1,529 | 2,300 | 1,555 | 982 | 830 |
| Total Expenses | - | - | - | - | - | - | - |
| Profit Before exceptional items and Tax | 6.3% | 525 | 494 | 793 | 337 | 156 | 217 |
| Profit Before exceptional items and Tax | - | - | - | - | - | - | - |
| Exceptional items before tax | 35.9% | 0 | -0.56 | 0 | 0 | 0 | 0 |
| Total profit before tax | 6.5% | 525 | 493 | 793 | 337 | 156 | 217 |
| Total profit before tax | - | - | - | - | - | - | - |
| Current tax | 7.1% | 137 | 128 | 205 | 88 | 43 | 56 |
| Current tax | - | - | - | - | - | - | - |
| Deferred tax | 28.7% | -1.54 | -2.56 | -2.58 | -1.4 | -1.91 | -5.44 |
| Deferred tax | - | - | - | - | - | - | - |
| Total tax | 7.2% | 135 | 126 | 202 | 86 | 41 | 51 |
| Total tax | - | - | - | - | - | - | - |
| Total profit (loss) for period | 6% | 390 | 368 | 591 | 251 | 115 | 166 |
| Total profit (loss) for period | - | - | - | - | - | - | - |
| Other comp. income net of taxes | -85.6% | -2.34 | -0.8 | 0.63 | 2.71 | 2.33 | -3.52 |
| Other comp. income net of taxes | - | - | - | - | - | - | - |
| Total Comprehensive Income | 5.5% | 387 | 367 | 591 | 253 | 117 | 163 |
| Total Comprehensive Income | - | - | - | - | - | - | - |
| Earnings Per Share, Basic | 6.1% | 127.09 | 119.88 | 192.63 | 81.758 | 37.49 | 54.31 |
| Earnings Per Share, Basic | - | - | - | - | - | - | - |
| Earnings Per Share, Diluted | 6.1% | 127.09 | 119.88 | 192.63 | 81.758 | 37.49 | 54.31 |
| Earnings Per Share, Diluted | - | - | - | - | - | - | - |
| 15.4% |
| 31 |
| 27 |
| 28 |
| 30 |
| 19 |
| 40 |
| Non-current investments | 41.1% | 255 | 181 | 181 | 0 | 53 | 53 |
| Loans, non-current | -90% | 0.81 | 0.9 | 1.25 | 0 | 1.38 | 0.91 |
| Total non-current financial assets | -1.3% | 390 | 395 | 194 | 129 | 66 | 62 |
| Total non-current assets | 0.8% | 732 | 726 | 541 | 481 | 415 | 401 |
| Total assets | 4.1% | 2,524 | 2,424 | 2,263 | 2,044 | 1,827 | 1,772 |
| Borrowings, non-current | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Total non-current financial liabilities | 2266.7% | 3.6 | 0.88 | 1.75 | 2.47 | 0 | 0 |
| Total non-current liabilities | 2266.7% | 3.6 | 0.88 | 1.75 | 2.47 | 2.88 | 0.82 |
| Borrowings, current | - | 0 | 0 | 0 | 0 | 9.16 | 27 |
| Total current financial liabilities | -29.2% | 110 | 155 | 163 | 136 | 85 | 202 |
| Provisions, current | 14.3% | 33 | 29 | 28 | 20 | 19 | 16 |
| Current tax liabilities | -66.8% | 5.32 | 14 | 17 | 15 | 26 | 24 |
| Total current liabilities | -22.4% | 160 | 206 | 219 | 180 | 137 | 249 |
| Total liabilities | -20.9% | 164 | 207 | 221 | 183 | 140 | 250 |
| Equity share capital | 0% | 15 | 15 | 15 | 15 | 15 | 15 |
| Total equity | 6.4% | 2,360 | 2,218 | 2,042 | 1,861 | 1,688 | 1,522 |
| Total equity and liabilities | 4.1% | 2,524 | 2,424 | 2,263 | 2,044 | 1,827 | 1,772 |
| 98% |
| 0 |
| -47.93 |
| 0 |
| 0 |
| - |
| - |
| Income taxes paid (refund) | 0% | 138 | 138 | 209 | 77 | - | - |
| Other inflows (outflows) of cash | - | 0 | 0 | 0 | 1.02 | - | - |
| Net Cashflows From Operating Activities | -67.8% | 196 | 606 | 434 | 51 | - | - |
| Cashflows used in obtaining control of subsidiaries | 4.9% | 65 | 62 | 0 | 0.07 | - | - |
| Proceeds from sales of PPE | - | 0.28 | 0 | 0.42 | 0.24 | - | - |
| Purchase of property, plant and equipment | -41.3% | 38 | 64 | 81 | 61 | - | - |
| Proceeds from sales of investment property | -69.5% | 0 | 0.41 | 0 | 0 | - | - |
| Purchase of intangible assets | - | 0 | 0 | 0 | 0.34 | - | - |
| Interest received | 46.7% | 67 | 46 | 11 | 5.97 | - | - |
| Other inflows (outflows) of cash | -72.9% | -603.8 | -348.89 | -5.08 | -0.44 | - | - |
| Net Cashflows From Investing Activities | -48.9% | -639.13 | -429.02 | -84.74 | -56.18 | - | - |
| Repayments of borrowings | -103.8% | 0 | 27 | 36 | 32 | - | - |
| Payments of lease liabilities | - | 2.09 | 0 | 0.14 | 0 | - | - |
| Dividends paid | 11.1% | 31 | 28 | 28 | 34 | - | - |
| Interest paid | - | 1.43 | 0 | 4.44 | 3.7 | - | - |
| Other inflows (outflows) of cash | 85% | 0.33 | -3.47 | -0.67 | 27 | - | - |
| Net Cashflows from Financing Activities | 41.4% | -33.84 | -58.42 | -68.55 | -41.65 | - | - |
| Net change in cash and cash eq. | -508.8% | -477.33 | 118 | 280 | -47.09 | - | - |